Literature DB >> 10679100

Purification and characterization of two mannan-binding lectins from mouse serum.

S Hansen1, S Thiel, A Willis, U Holmskov, J C Jensenius.   

Abstract

Mannan-binding lectin (MBL) is a serum protein that activates the complement system after binding to glycoconjugates found on the surface of microorganisms. By molecular cloning two forms of MBL have been identified in the mouse (mMBL-A and mMBL-C), but only mMBL-A has been purified and characterized at the protein level. MBL-C has been termed the liver form of MBL. The present report describes the purification and characterization of mMBL-A and mMBL-C from serum. The two forms of mMBL could be separated both by ion-exchange and carbohydrate-affinity chromatography. The initial identification by immunochemical technique was confirmed by N-terminal amino-acid sequencing. Both proteins give bands corresponding to polypeptide chains of 28 kDa on SDS-PAGE in the reduced state, but mMBL-A migrated more rapidly than mMBL-C in acid/urea-PAGE, in accordance with the calculated pIs. Both forms mediated activation of complement component C4 in mannan-coated microtiter wells. MBL-A showed a higher affinity for d -glucose and alpha-methyl-d -glucose then did MBL-C. Serum concentrations of mMBL-A in laboratory strains and wild mice were found to vary from 5 to 80 microg/ml, with wild mice tending to show higher levels than laboratory strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10679100     DOI: 10.4049/jimmunol.164.5.2610

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin.

Authors:  Wei-Chuan Chang; Kevan L Hartshorn; Mitchell R White; Patience Moyo; Ian C Michelow; Henry Koziel; Bernard T Kinane; Emmett V Schmidt; Teizo Fujita; Kazue Takahashi
Journal:  Biochem Pharmacol       Date:  2010-10-28       Impact factor: 5.858

2.  Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury.

Authors:  Daiana De Blasio; Stefano Fumagalli; Luca Longhi; Franca Orsini; Alessandro Palmioli; Matteo Stravalaci; Gloria Vegliante; Elisa R Zanier; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

3.  Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection.

Authors:  Kazue Takahashi; Lei Shi; Lakshmi D Gowda; R Alan B Ezekowitz
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.

Authors:  Kileen L Mershon-Shier; Alex Vasuthasawat; Kazue Takahashi; Sherie L Morrison; David O Beenhouwer
Journal:  Mol Immunol       Date:  2011-07-01       Impact factor: 4.407

5.  Disseminated candidiasis and hepatic malarial infection in mannose-binding-lectin-A-deficient mice.

Authors:  Sena J Lee; Gloria Gonzalez-Aseguinolaza; Michel C Nussenzweig
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

6.  Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.

Authors:  Franca Orsini; Pia Villa; Sara Parrella; Rosalia Zangari; Elisa R Zanier; Raffaella Gesuete; Matteo Stravalaci; Stefano Fumagalli; Roberta Ottria; José J Reina; Alessandra Paladini; Edoardo Micotti; Renato Ribeiro-Viana; Javier Rojo; Vasile I Pavlov; Gregory L Stahl; Anna Bernardi; Marco Gobbi; Maria-Grazia De Simoni
Journal:  Circulation       Date:  2012-08-09       Impact factor: 29.690

7.  Mannose-binding lectin and its associated proteases (MASPs) mediate coagulation and its deficiency is a risk factor in developing complications from infection, including disseminated intravascular coagulation.

Authors:  Kazue Takahashi; Wei-Chuan Chang; Minoru Takahashi; Vasile Pavlov; Yumi Ishida; Laura La Bonte; Lei Shi; Teizo Fujita; Gregory L Stahl; Elizabeth M Van Cott
Journal:  Immunobiology       Date:  2010-03-04       Impact factor: 3.144

8.  Involvement of the lectin pathway of complement activation in antimicrobial immune defense during experimental septic peritonitis.

Authors:  Michaela Windbichler; Bernd Echtenacher; Thomas Hehlgans; Jens C Jensenius; Wilhelm Schwaeble; Daniela N Männel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Mitochondria and the lectin pathway of complement.

Authors:  Christel R Brinkmann; Lisbeth Jensen; Frederik Dagnæs-Hansen; Ida E Holm; Yuichi Endo; Teizo Fujita; Steffen Thiel; Jens C Jensenius; Søren E Degn
Journal:  J Biol Chem       Date:  2013-02-01       Impact factor: 5.157

10.  Species differences in the carbohydrate binding preferences of surfactant protein D.

Authors:  Erika C Crouch; Kelly Smith; Barbara McDonald; David Briner; Bruce Linders; Joseph McDonald; Uffe Holmskov; James Head; Kevan Hartshorn
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.